Helen Keller International   Report issue

Academic/Hospital Phase 4
Founded: New York NY United States (1915)

Organization Overview

First Clinical Trial
2009
NCT00944398
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Helen Keller International

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Diarrhea (Phase 4)

Inflammation (Phase 4)

Malaria (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 10